The Comparative Immunotherapy Program led by Penn Vet’s Nicola Mason is redefining how therapies are developed and tested—uniting human and veterinary medicine to move promising immunotherapies forward.
Zoey the cockapoo greeted life with tail-wagging joy. A mass of tawny curls, she loved everyone, and they loved her back.
Something about Litte Dove just wasn’t quite right. Even in her favorite Philly park with her favorite people, the usually plucky shepherd mix sat down abruptly in mid-walk.
Efficient delivery of synthetic mRNA to the retina remains one of the key hurdles in developing mRNA-based treatments for vision loss.
NBC10
New York Times/Wirecutter
AVMA
